CBST Insider Trading Activity and SEC Form 4 Filings
CBST insider trading summary
No open-market insider purchases or sales of Cubist Pharmaceuticals Inc (CBST) have been reported on SEC Form 4 in the past 12 months.
Latest CBST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 1, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $27K (400 @ $66.50) |
| Oct 1, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $1.7M (25,500 @ $65.11) |
| Oct 1, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $1.5M (22,225 @ $65.68) |
| Aug 19, 2014 | Gregory Stea | SVP, Commercial Operations | Sell | $2.5M (38,326 @ $65.88) |
| Aug 18, 2014 | Robert J Perez | President & COO | Sell | $64K (1,003 @ $63.68) |
| Aug 18, 2014 | Nancy J Hutson | Director | Sell | $585K (9,000 @ $65.00) |
| Aug 18, 2014 | Michael John Tomsicek | SVP & Chief Financial Officer | Sell | $26K (409 @ $63.68) |
| Jul 28, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $407K (6,525 @ $62.44) |
| Jul 28, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $2.1M (34,100 @ $61.40) |
| May 15, 2014 | Steven C Gilman | EVP & Chief Scientific Officer | Sell | $82K (1,215 @ $67.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.